In English | En español
Questions About Cancer? 1-800-4-CANCER

NCI Drug Dictionary

  

FAK inhibitor VS-6063 
An orally bioavailable, small-molecule focal adhesion kinase (FAK) inhibitor with potential antiangiogenic and antineoplastic activities. FAK inhibitor VS-6063 inhibits FAK, which may prevent the integrin-mediated activation of several downstream signal transduction pathways, including those involving RAS/MEK/ERK and PI3K/Akt, thus inhibiting tumor cell migration, proliferation, survival, and tumor angiogenesis. The tyrosine kinase FAK, a signal transducer for integrins, is normally activated by binding to integrins in the extracellular matrix (ECM) but may be upregulated and constitutively activated in various tumor cell types. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Code names:PF-04554878
VS-6063